Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation: Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF. Mediterr J Hematol Infect Dis [Internet]. 2022 Feb. 27 [cited 2026 Apr. 29];14(1):e2022025. Available from: https://www.mjhid.org/mjhid/article/view/4856